Management of heart failure: A challenge for healthcare systems;L'insuffisance cardiaque et son traitement: Un enjeu pour les systèmes de santé

Bulletin de l'Academie Nationale de Medecine

Volumn 196, Issue 6, 2012, Pages 1159-1167

  Komajda, Michel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Devices; Heart failure; Pharmacology; Treatment

Indexed keywords

EID: 84875757731     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)31745-5     Document Type: Article

References (16)

1. MOSTERD A., HOES A. W. - Clinical epidemiology of heart failure. Heart. 2001, 93, 1137-1146.
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Coopérative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med., 1987, 316, 1429-1435.
3. FLATHER M. D., YUSUF S., KOBER L., PFEFFER M., HALL A., MURRAY G. et al. - Long-term ACE-inhibitor therapy in patients with heart failure of left ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000, 355, 1575-1581. (Pubitemid 30240501)
4. GRANGER C. B., MCMURRAY J. J., YUSUF S., HELD P., MICHELSON E. L., OLOFSSON B. et al. - Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM Alternative trial. Lancet. 2003, 362, 112-116.
5. PACKER M., BRISTOW MR, COHN JN, COLUCCI WS, FOWLER MB, GILBERT EM et al. - The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N. Engl. J. Med., 1996, 334, 1349-1355. (Pubitemid 26152713)
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999, 353, 2001-2007.
7. PITT B., ZANNAD F., REMME W. J., CODY R., CASTAIGNE A., PEREZ A. et al. - The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med., 1999, 341, 709-717. (Pubitemid 29407370)
8. ZANNAD F., MCMURRAY J. J., KRUM H., VAN VELDHUISEN D. J., SWEDBERG K., SHI H. et al. - Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med., 1999, 341, 709-717. (Pubitemid 29407370)
9. SWEDBERG K., KOMAJDA M., BOHM M., BORER J. S., FORD I., DUBOST-RAMA A. et al. - Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010, 376, 875-885.
10. BARDY G. H., LEE K. L., MARK D. B., POOLE J. E., PACKER D. L., BOINEAU R. et al. - Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 2005, 352, 225-237. (Pubitemid 40110811)
11. BRISTOW M. R., SAXON L. A., BOEHMER J., KRUEGER S., KASS D. A., DE MARCO T. et al. - Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med., 2004, 350, 2140-2150.
12. CLELAND J. G., DAUBERT J. C., ERDMANN E., FREEMANTLE N., GRAS D., KAPPENBERGER L. et al. - The effect of cardiac resynchronization on morbitidy and mortality in heart failure. N. Engl. J. Med., 2005, 352, 1539-1549. (Pubitemid 40517094)
13. MOSS A. J., HALL W. J., CANNOM D. S., KLEIN H., BROWN M. W., DAUBERT J. P. et al. - Cardiac resynchronization therapy for the prevention of heart failure events. N. Engl J. Med., 2009, 361, 1329-1338.
14. TANG A. S., WELLS G. A., TALAJIC M., ARNOLD M. O., SHELDON R., CONNOLLY S. et al. - Cardiac resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med, 2010, 363, 2385-2395.
15. YUSUF F., PFEFFER M. A., SWEDBERG K., GRANGER C. B., HELD P., MCMURRAY J. J. et al. - Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003, 362, 777-781. (Pubitemid 37093918)
16. MASSIE B. M., CARSON P. E., MCMURRAY J. J., KOMAJDA M., MCKELVIE R., ZILE M. R. et al. - Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med., 2008, 359, 2456-2467.